Using computational phantoms to improve delivery of Tumor Treating Fields (TTFields) to patients

This paper reviews the state-of-the-art in simulation-based studies of Tumor Treating Fields (TTFields) and highlights major aspects of TTFields in which simulation-based studies could affect clinical outcomes. A major challenge is how to simulate multiple scenarios rapidly for TTFields delivery. Overcoming this challenge will enable a better understanding of how TTFields distribution is correlated with disease progression, leading to better transducer array designs and field optimization procedures, ultimately improving patient outcomes.

[1]  Pedro Cavaleiro Miranda,et al.  Modelling Tumor Treating Fields for the treatment of lung-based tumors , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[2]  Hassan M. Fathallah-Shaykh,et al.  Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme , 2016, PloS one.

[3]  P. Basser,et al.  Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts. , 2016, International journal of radiation oncology, biology, physics.

[4]  Ricardo Salvador,et al.  The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study , 2015, Physics in medicine and biology.

[5]  E. Dekel,et al.  Disruption of cancer cell replication by alternating electric fields. , 2004, Cancer research.

[6]  Alfredo Quinones-Hinojosa,et al.  Glioblastoma recurrence patterns near neural stem cell regions. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Charles Scott,et al.  NT-40Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM , 2014 .

[8]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[9]  Moshe Giladi,et al.  Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo. , 2014, Seminars in oncology.

[10]  P. Basser,et al.  Predicting the electric field distribution in the brain for the treatment of glioblastoma , 2014, Physics in medicine and biology.

[11]  Edwin Lok,et al.  Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations , 2015, Expert review of medical devices.

[12]  Noa Urman,et al.  Abstract 3804: Disruption of spindle microtubules by TTFields result in abnormal chromosomes segregation and subsequent caspase-dependent cell death , 2015 .

[13]  E. Dekel,et al.  Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors , 2007, Proceedings of the National Academy of Sciences.

[14]  J. Lemée,et al.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. , 2015, Neuro-oncology.